Every test came back normal – until one of the doctors finally came up with possible diagnosis - Dravet Syndrome, also known as myoclonic epilepsy of infancy (SMEI).

Dravet syndrome, formerly called severe myoclonic epilepsy of infancy (SMEI), is a form of epilepsy that begins at a very young age, often in early infancy.

Severe myoclonic epilepsy in infants (SMEI), also known as Dravet syndrome, is a rare, refractory form of epilepsy, for which stiripentol (STP) has been recently licensed as add-on therapy.

To evaluate the efficacy and tolerability of STP and other antiepileptic drug treatments (including ketogenic diet) for patients with SMEI.